%0 Journal Article %A Yair Bannett %A Rebecca M. Gardner %A Lynne C. Huffman %A Heidi M. Feldman %A Lee M. Sanders %T Continuity of Care by Primary Care Provider in Young Children with Chronic Conditions %D 2021 %R 10.1101/2021.02.04.21251018 %J medRxiv %P 2021.02.04.21251018 %X Objectives (1) To assess continuity of care by primary-care provider (CoC), an established quality indicator, in children with asthma, autism spectrum disorder (ASD), and no chronic conditions, and (2) to determine patient factors that influenced CoC.Methods Retrospective cohort study of electronic health records from all office visits of children under 9 years, seen ≥4 times between 2015 and 2019 in 10 practices of a community-based primary healthcare network in California. Three cohorts were constructed: (1)Asthma: ≥2 visits with asthma visit diagnoses; (2)ASD: same method; (3)Controls: no chronic conditions. CoC, using the Usual Provider of Care measure (range >0-1), was calculated for (1)total visits and (2)well-care visits only. Fractional regression models examined CoC adjusting for patient age, medical insurance, practice affiliation, and number of visits.Results Of 30,678 eligible children, 1875 (6.1%) were classified as Asthma, 294 (1.0%) as ASD, and 15,465 (50.4%) as Controls. Asthma and ASD had lower total CoC than Controls (Mean=0.58, SD 0.21, M=0.57, SD 0.20, M=0.66, SD 0.21). Differences among well-care CoC were smaller (Asthma M=0.80, ASD M=0.78, Controls M=0.82). In regression models, lower total CoC was found for Asthma (aOR 0.90, 95% CI 0.85-0.94). Lower total and well-care CoC were associated with public insurance (aOR 0.77, CI 0.74-0.81; aOR 0.64, CI 0.59-0.69).Conclusion Children with asthma in this primary-care network had lower CoC compared to children without chronic conditions. Public insurance was the most prominent patient factor associated with low CoC. Quality initiatives should address disparities in CoC for children with chronic conditions.Table of Contents Summary Continuity of care by primary care provider is an established quality indicator. We compared continuity in young children with asthma, autism, and no chronic conditions.What’s Known on This Subject Continuity of care has emerged as an important component of care in the patient-centered medical home, especially for children with chronic medical conditions. However, it has been minimally studied across chronic conditions, especially in neurodevelopmental disorders.What This Study Adds Children with asthma, but not those with autism spectrum disorder, had lower continuity of care compared to children without chronic conditions. Public insurance was associated with lower care continuity for children with and without chronic conditions, highlighting important sociodemographic disparities.Contributors’ Statement Page Dr. Bannett conceptualized and designed the study, defined and coordinated data extraction, carried out the data analyses, drafted the manuscript, and reviewed and revised the manuscript.Ms. Gardner participated in study design, extensively reformatted the data for analysis, performed statistical data analysis, and critically reviewed and revised the manuscript.Dr. Feldman participated in study design, supervised data analysis and critically reviewed and revised the manuscript.Drs. Huffman and Sanders supervised the conceptualization and design of the study, supervised data analysis, and critically reviewed and revised the manuscript.All authors approved the final manuscript as submitted and are responsible for all aspects of the work.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a research grant from the Society for Developmental and Behavioral Pediatrics (Dr. Bannett). The authors have no financial relationships relevant to this article to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University School of Medicine institutional review boardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets used for this study must be completely de-identified according to federal regulations prior to release for sharing. Given the potentially sensitive nature of these data, we will make the datasets available only under a data-sharing plan. Requests to use the information and data from this study will be considered on a case-by-case basis, following written request to the corresponding author.AAPAmerican Academy of PediatricsADHDAttention-Deficit/Hyperactivity DisorderASDAutism Spectrum DisorderCoCContinuity of CareEHRElectronic Health RecordPCHAPackard Children’s Health AlliancePCPPrimary Care Provider %U https://www.medrxiv.org/content/medrxiv/early/2021/02/08/2021.02.04.21251018.full.pdf